The treatment of High Blood Pressure & Stress with vitamins

High Blood Pressure and Stress: Mitamins custom make quality formulas for the treatment of High Blood Pressure & Stress with vitamins. A High Blood Pressure & Stress formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: High Blood Pressure and Stress

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin B6
    50
    mg
    2500%
    Choline Bitartrate
    50
    mg
    *
    CoQ-10
    60
    mg
    *
    Flax Seed Powder
    50
    mg
    *
    Omega - 3 Fatty Acids
    100
    mg
    *
    Garlic Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Eleuthero Extract
    50
    mg
    *
    Hawthorn Extract
    100
    mg
    *
    Reishi Extract
    50
    mg
    *
    Taurine
    50
    mg
    *
    L-Tyrosine
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
High Blood Pressure and Stress
Serving Size:4-5

High Blood Pressure and Stress Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
King Pharmaceuticals And Palatin Technologies Announce End-of-Phase 2 Meeting With FDA For Bremelanotide
Palatin Technologies, Inc. (Amex: PTN) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration (FDA) has scheduled an End-of-Phase 2 meeting to discuss clinical study results with bremelanotide for the treatment of erectile dysfunction (ED). Palatin Technologies submitted a meeting request to FDA in May 2007; FDA has scheduled the meeting for August 2007.
Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
The first reported findings from an international, Phase 3 study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of ustekinumab (CNTO 1275) achieved at least a 75 percent reduction in psoriasis at week 12, the primary endpoint of the study, as measured by the Psoriasis Area and Severity Index (PASI 75).
This information concerning the support of High Blood Pressure and Stress treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments